The six-month remaining shelf-life threshold for imports

Updated: 2026-11-11 · GRZAN Regulatory Team · Verification date 2026-10-20

1. Key takeaways

RTS 11.03.02:21 applies a single shelf-life threshold to imports. Article 6.4.1 c), for routine imports, provides that the remaining validity of the device must be not less than six months. Article 6.4.2 b), for special imports, sets the same threshold of six months but allows conditional treatment in special cases, on the responsibility of the person carrying out the procedure and subject to authorisation by the authority.

The threshold is independent of whether the product has been approved. A device with a valid sanitary registration that arrives with insufficient remaining shelf life still cannot be imported, because the requirement attaches to the condition of the goods at the time of the import declaration rather than to the status of the registration.

Two further consequences follow from the design of the rule. The first is that the calculation has to be made backwards from the intended date of import rather than forwards from the date of manufacture, which brings shipping time and clearance time into the production plan. The second is that the same date has to appear consistently in three places, because the invoice, the label and the physical batch are all checked against each other.

2. Legal basis

The threshold itself, the documentary provisions that support it at registration and the labelling provision that carries it onto the product are set out below.

LevelInstrumentReferencePublication dateProvisionSubstance
Technical regulationRTS 11.03.02:21Acuerdo No. 14-20222022-08-23Article 6.4.1 c)Routine import: remaining validity not less than six months
Technical regulationRTS 11.03.02:21Acuerdo No. 14-20222022-08-23Article 6.4.2 b)Special import: also six months; special cases on the responsibility of the applicant and subject to authorisation by the authority
Technical regulationRTS 11.03.02:21Acuerdo No. 14-20222022-08-23Article 6.4.1 e)The invoice must state the expiry date where applicable
Technical regulationRTS 11.03.02:21Acuerdo No. 14-20222022-08-23Article 6.3.2.2 b)IVDs must submit a technical file on shelf life or stability
Technical regulationRTS 11.03.02:21Acuerdo No. 14-20222022-08-23Article 6.3.2.5 c)Other devices must submit validation documents supporting shelf life
Technical regulationRTS 11.03.02:21Acuerdo No. 14-20222022-08-23Article 6.3.4 d), item 11Primary packaging label must state the expiry date where applicable

The provisions cited in this article are Articles 6.3.2.2 b), 6.3.2.5 c), 6.3.4 d) item 11, 6.4.1 c) and e), 6.4.2 b) and 6.5.1 d) of RTS 11.03.02:21, Dispositivos Médicos. Requisitos para la Regulación Sanitaria de Dispositivos Médicos (Acuerdo No. 14-2022, Diario Oficial No. 156, Tomo No. 436, 2022-08-23).

Regulatory information verified as at 29 October 2026.

3. Expert insights

Insight one: six months refers to remaining shelf life, so shipping and transit must be worked backwards. The provision states that the expiry date of the medical device must not be less than six months, and the point of assessment falls at the import declaration. Transit to Central America plus clearance is normally measured in weeks rather than days. For IVD reagents and some consumables, where the total shelf life is itself short, production scheduling has to be calculated backwards from the arrival date. Waiting until the goods reach port to discover that the remaining life is insufficient leaves no remedy at that stage.

Insight two: the threshold is identical for routine and special imports, but the flexibility is not. Both provisions state six months. The difference is the additional wording in Article 6.4.2 b), which preserves special cases and conditions them on the responsibility of the applicant and on the corresponding authorisation. Donations of short-dated product therefore have room to apply, but responsibility rests with the applicant and an express authorisation must be obtained. Routine commercial imports have no such flexibility, and the special-case mechanism cannot be invoked to rescue them.

Insight three: the import threshold and the registration-stage shelf-life validation are two links in one chain. Article 6.3.2.2 b) for IVDs and Article 6.3.2.5 c) for other devices both require validation documents supporting the claimed shelf life. If the validation supports only a shelf life of six months or less in total, the product may pass registration and yet be systematically blocked at import, because by the time it ships the remaining life will fall below the threshold. GRZAN reviews shelf-life validation and the import threshold together as a single point of assessment rather than as two separate questions.

Insight four: the invoice and the label must both carry the date, and the three data points must agree. Article 6.4.1 e) requires the invoice to state the expiry date where applicable, and Article 6.3.4 d) item 11 requires the primary packaging label to state it where applicable. If the expiry on the invoice, the expiry on the label and the batch actually presented disagree, the discrepancy is direct physical evidence in an unannounced inspection under Article 6.5.1 d). A mismatch of this kind is difficult to explain as clerical, because it touches the batch identity itself.

4. Practical recommendations

  • Work the six-month remaining-life requirement backwards into production scheduling, particularly for IVDs and short-dated consumables.
  • For short-dated donated products, apply under the special-case mechanism in Article 6.4.2 b), accept responsibility in writing and obtain the authorisation before shipment.
  • Design shelf-life validation at registration to support a remaining life above six months at the point of import, not merely at the point of manufacture.
  • Keep the expiry date consistent across the invoice, the primary packaging label and the physical batch.
  • Where a product has no defined expiry, state the basis for that determination in writing in the registration file.
  • Run a remaining-shelf-life check before dispatch, so that a shortfall is identified at the factory rather than at the border.

5. Verification checklist

  • □ Remaining shelf life calculated backwards into the production schedule
  • □ Special-case authorisation obtained for short-dated donated products
  • □ Shelf-life validation supports more than six months of remaining life at import
  • □ Invoice expiry matches the label and the physical batch
  • □ Basis for products without a defined expiry documented in writing
  • □ Pre-dispatch remaining-life check completed
  • □ Expiry field completed on the invoice and on the primary packaging label where applicable

How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support for the Salvadoran market. Our team manages Ministry of Health (MINSAL) sanitary registration applications, prepares Spanish-language dossiers, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com

Disclaimer

Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.

About GRZAN

GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.

GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.

Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.

What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.

Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.

Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.

Take your devices global with GRZAN

We work with manufacturers worldwide to open new markets with a clear regulatory pathway.

Contact us
WhatsApp
QR Code
WhatsApp QR Code
Scan to chat on WhatsApp
Phone
Call
Office Mon-Fri 9:00-18:00
0755-88659477
Mobile 24/7 Service
+86 15816864648
Email
Mail